Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
COP1 (Constitutive Photomorphogenic 1, RFWD2) is a crucial E3 ubiquitin ligase responsible for mediating the ubiquitination and subsequent proteolysis of target proteins. It plays vital roles in processes such as cell proliferation, cell cycle progression, transcription regulation, and apoptosis, particularly significant in tumorigenesis, cell repair, and regulation. The study of the COP1 gene has revealed its highly conserved structure and function across various cell organisms and its relationship with diseases like cancer, making it a hot topic in molecular biology research.
The COP1 gene is located on human chromosome 1q24.1 and encodes a COP1 protein primarily composed of three highly conserved domains: an N-terminal RING finger domain, a coiled-coil region, and a C-terminal 7 WD40 repeat domain. COP1's E3 ubiquitin ligase function depends on the RING finger domain, which helps to transport active ubiquitin molecules to target proteins using E2 ubiquitin-conjugating enzymes therefore completing the ubiquitination process. Key to the WD40's activity is its repeated mediation of COP1's interactions with its target proteins. Important for its function in cell cycle control and response to external stimuli, COP1 also includes nuclear localization signals (NLS) and nuclear export signals (NES), which lets it shuttle between the nucleus and cytoplasm.
COP1 functions not only through its RING domain's direct action on substrates but also by forming complexes with other proteins to mediate protein degradation indirectly. For instance, a large complex comprising COP1 with CUL4A and DDB1 regulates the degradation of substrates such as c-Jun, demonstrating its diverse regulatory modes.
Figure 1. Blue light suppression of COP1/SPA E3 ligase promotes photomorphogenesis. (Ponnu J, 2020)
COP1 can either promote or inhibit tumorigenesis, depending on the target proteins and the specific context of its expression. Studies have shown that COP1 is overexpressed in many tumors, including leukemia, lymphoma, melanoma, glioma, breast cancer, lung cancer, and colorectal cancer. Overexpressed COP1 can promote cancer cell proliferation and inhibit apoptosis, facilitating tumor progression.
For example, COP1 suppresses the tumor suppressor function of p53 by ubiquitinating and degrading it, promoting cancer cell survival. In glioma cells, COP1 upregulation reduces p53 levels, accelerating cell proliferation. Similarly, COP1 overexpression promotes tumor progression in chronic lymphocytic leukemia (CLL) and hepatocellular carcinoma (HCC).
COP1's regulation of c-Jun also indicates its oncogenic role. c-Jun is a key transcription factor involved in regulating cell proliferation and stress responses. By ubiquitinating and degrading c-Jun, COP1 regulates cell growth and apoptosis, highlighting its central role in intracellular signaling.
However, COP1 may also have inhibitory roles in some tumors through other pathways. For instance, COP1 gene deletion in certain mouse models leads to embryonic lethality and cardiac abnormalities, indicating COP1's critical importance for organism survival. Moreover, some studies suggest COP1 may suppress tumorigenesis by regulating tumor suppressors like p27 and 14-3-3σ.
COP1 targets a variety of proteins, including p53, p27, c-Jun, and 14-3-3σ, which play crucial roles in the cell cycle, transcriptional regulation, and apoptosis. Through its E3 ubiquitin ligase activity, COP1 ubiquitinates these proteins, mediating their degradation and regulating cell growth, division, and death.
p53 Protein: p53 is a well-known protein that helps prevent tumors by controlling the cell cycle and starting the process of cell death. COP1 works directly with p53 using its RING finger part. This action leads to the tagging of p53 for destruction, which reduces its ability to fight tumors. In different types of cancer, high levels of COP1 are linked to lower amounts of p53 protein. This shows that COP1 is important in the development of tumors.
p27 Protein: p27 is a negative regulator of the cell cycle, especially crucial during the transition from the G0/G1 phase to the S phase. COP1 accelerates the cell cycle by directly binding to p27, promoting its polyubiquitination and degradation. This role has been confirmed in multiple cancers, such as breast cancer and osteosarcoma, correlating with tumor malignancy.
c-Jun Protein: c-Jun is an important transcription factor involved in cell growth and stress response control. COP1 helps tumors grow by breaking down c-Jun through a process called ubiquitination. High levels of c-Jun are often linked to the growth and spread of cancer cells, and COP1's role in regulating c-Jun presents a new target for cancer treatment.
14-3-3σ and C/EBPα: By targeting tumor suppressors like 14-3-3σ and C/EBPα, COP1 promotes their degradation, affecting tumor cell growth and differentiation. The degradation of these target proteins plays a regulatory role in tumor progression, demonstrating COP1's dual role in cancer.
The mechanism of action of COP1 as an E3 ubiquitin ligase provides new perspectives for cancer treatment. Modulating COP1 activity can effectively control cancer-associated signaling pathways, thereby inhibiting tumor growth or promoting tumor cell death. COP1 inhibitors hold promise as a novel anti-cancer therapy, particularly in cancers with p53 inactivation and other tumor suppressor impairments, as they may restore the functions of these tumor suppressors.
Additionally, the selectivity of COP1 targets offers great potential as a therapeutic target. As more is learned about COP1's mechanism and target proteins through further research, we are likely to discover more COP1 targets, providing a basis for precision cancer therapy. Future research should focus on unveiling the details of COP1's regulatory network and how to leverage this network to develop innovative cancer treatments.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.